Therapeutic effect of Gliflozins in Nonalcoholic Hepatic Steatosis

Antonella Maribel Salto and Marcelo Adrián Estrin

SCT Proceedings in Interdisciplinary Insights and Innovations, 2023, vol. 1, 10.56294/piii2023149

Abstract: The disease called non-alcoholic fatty liver (NAFLD its acronym in English) is the most common chronic liver disease worldwide, its general prevalence is high, on average 25%. One study showed that the prevalence of NAFLD is increasing with approximately 3.6 million cases each year. Metabolic stress is closely related to insulin resistance (IR). It is frequently associated with metabolic syndromes such as obesity and dyslipidemia. Systematic review with qualitative and quantitative database of the platform PUBMED. The articles were downloaded from the PUBMED platform and the Zotero program was used to make proper citations and references. Articles that include adult patients of both biological sexes will be analyzed

Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:procee:v:1:y:2023:i::p:1056294piii2023149:id:1056294piii2023149

Access Statistics for this article

More articles in SCT Proceedings in Interdisciplinary Insights and Innovations from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().